Healthtech startup DocTalk raises Rs 32 crore from Matrix, Khosla Ventures

Published On 2017-11-12 04:17 GMT   |   Update On 2017-11-12 04:17 GMT

DocTalk, a Mumbai based healthcare startup has raised $5 million (Rs 32.43 crore) in its new round of fundingThe funding was raised from Matrix Partners India, Khosla Ventures, Venture Highway, Liquid 2 Ventures, Altair Capital and Vy Capital, along with a few undisclosed angel investors.


The company will use the fresh capital to expand its team and onboard hospital chains on its platform.


Akshat Goenka, founder, and CEO, DocTalk told TOI, "We are looking to hire across departments such as sales, operations, and technology as we plan to expand into new cities. We also have to develop a deeper presence in our existing markets."


The startup aims to address the doctor-patient communication problem giving doctors the chance to engage with patients post consultation as well. They aim to enable doctors to plug revenue leakage as well as maintain relationships with patients through the entire treatment life-cycle.


Founded in 2016 by Akshat Goenka, Krishna Chaitanya Aluru and Vamsee Chamarkura little over a year ago, DocTalk claims to have about 500 doctors using its services serving about 30,000 patients so far. At present DocTalk have operations in Delhi, Mumbai, and Hyderabad.


Speaking to TOI, Krishna Chaitanya Aluru, CTO, said "While growing up, I would see my father (who is a doctor) be constantly inundated with calls and messages, only a small fraction of which were emergencies. At DocTalk, we are working hard to simplify and improve doctors' lives by giving them complete control over their patient communication and practice."

Article Source : With inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News